Area of research
Genetics · Epidemiology
Research interest
Research interests include Inflammatory Bowel Disease, Microscopic Colitis, Eosinophilic Esophagitis, and Biosimilars and Bioanalytical Methods.
The Impact of Setons on Perianal Fistula Outcomes in Patients With Crohn's Disease Treated With Anti‐<scp>TNF</scp> Therapy: A Multicentre Study
Effectiveness of Reinduction and/or Dose Escalation of Ustekinumab in Crohn’s Disease: A Systematic Review and Meta-analysis
Development and Validation of Clinical Scoring Tool to Predict Outcomes of Treatment With Vedolizumab in Patients With Ulcerative Colitis
Systematic review with meta‐analysis: safety and tolerability of immune checkpoint inhibitors in patients with pre‐existing inflammatory bowel diseases
Comparative Safety and Effectiveness of Vedolizumab to Tumor Necrosis Factor Antagonist Therapy for Ulcerative Colitis
Shorter Disease Duration Is Associated With Higher Rates of Response to Vedolizumab in Patients With Crohn’s Disease But Not Ulcerative Colitis
Open: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium
Development and Validation of a Scoring System to Predict Outcomes of Vedolizumab Treatment in Patients With Crohn’s Disease
Retrospective Analysis of Safety of Vedolizumab in Patients With Inflammatory Bowel Diseases
Predictors and Management of Loss of Response to Vedolizumab in Inflammatory Bowel Disease
OP025 Comparative effectiveness of vedolizumab and tumour necrosis factor-antagonist therapy in Crohn’s disease: a multicentre consortium propensity score-matched analysis